Panitumumab-IRDye800 Clinical Trials
6 recruitingDrug
Phase 15Phase 25
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures
Brain Tumor
Stanford University12 enrolled1 locationNCT04085887
Recruiting
Phase 1Phase 2
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Pancreatic Adenocarcinoma
George Poultsides27 enrolled1 locationNCT03384238
Recruiting
Phase 1Phase 2
Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
Lung CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8+2 more
Stanford University30 enrolled1 locationNCT03582124
Recruiting
Phase 1Phase 2
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
Malignant Brain NeoplasmMalignant Glioma
Stanford University46 enrolled1 locationNCT03510208
Recruiting
Phase 2
Phase II Panitumumab-IRDye800 in Head & Neck Cancer
Head and Neck Cancer
University of Alabama at Birmingham25 enrolled1 locationNCT04511078
Recruiting
Phase 1
Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer
Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
Vanderbilt-Ingram Cancer Center40 enrolled1 locationNCT05945875